Spectrum Settles With Glaxo Over Imitrex
Specialty drug maker Spectrum Pharmaceuticals Inc. has settled a patent infringement suit with GlaxoSmithKline over the use of the migraine injection treatment Imitrex....To view the full article, register now.
Already a subscriber? Click here to view full article